Cantex and Headlamp Partner to Advance Azeliragon for MS Depression and Fatigue
Cantex Pharmaceuticals and Headlamp Health have announced a partnership to use Headlamp's Lumos AI platform to accelerate the development of azeliragon for treating severe depression and fatigue in multiple sclerosis patients.